Login

Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Burchill shares his perspective on what makes Mayo Clinic’s approach to ACHD special.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
From Military Service to Financial Advising: The Journey of Blue Sky Wealth Advisors
00:10:00
Brunswick Exploration: Pioneering Lithium Discovery and Development Across Canada's Prime Geological Regions
00:00:00
Edward M. Hundert, MD Former Dean for Medical Education
00:10:00
Annabel Huo, President of Comba Telecom International, is featured in an interview on Telecom TV|Mr. Fok Tung Ling is one of the founders of Comba Telecom Systems Holdings Limited.
00:00:00
Abivax seeks partners - Dr. Hartmut Ehrlich, CEO, Abivax
00:10:00
Unveiling Innovation at Zentiva's Cutting-Edge R&D Center: Pioneering Pharmaceutical Breakthroughs for a Healthier Tomorrow | STEFFEN SALTOFTE , CHIEF EXECUTIVE OFFICER OF ZENTIVA SA
00:10:00
Leading RL Commercial REIT with Humility and Purpose | Jericho Go, CEO, RL Commercial REIT.
00:10:00
WithSecure CEO Juhani Hintikka’s interview | Juhani Hintikka, CEO, WithSecure OyjWITH:HEX
00:10:00
Exploring Newfoundland: The Moosehead Gold Project
00:10:00
Victor Badin, CEO, Alpha Networks | Guillaume Devezeaux, CEO, Alpha Networks Inc3380:TAI
00:10:00
Origin Energy CFO Lawrie Tremaine discusses Origin's strong financial performance and strategic outlook.
00:10:00
Rincon Resources: Advancing Gold and Copper Projects in Western Australia's Rich Paterson Province

© 2017 - Neuhu+